Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Moleculin Biotech Inc. (MBRX)

0.9335   -0.026 (-2.7%) 01-21 16:00
Open: 0.925 Pre. Close: 0.9594
High: 0.94 Low: 0.9002
Volume: 358,866 Market Cap: 43M
Moleculin Biotech Inc is a preclinical stage pharmaceutical company. The company is engaged in the development of anti-cancer drug candidates. Its drug development technologies include liposomal Annamycin, WP1122 and WP1066.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 0.942 - 0.947 0.947 - 0.951
Low: 0.887 - 0.894 0.894 - 0.899
Close: 0.921 - 0.931 0.931 - 0.938

Technical analysis

as of: 2020-01-21 4:28:02 PM
Stoxline posted a SELL today, downgraded from higher rating. Downward movement to be expected.
Target: Six months: 1.12     One year: 1.20
Support: Support1: 0.85    Support2: 0.71
Resistance: Resistance1: 0.96    Resistance2: 1.03
Pivot: 0.94
Moving Average: MA(5): 0.95     MA(20): 0.95
MA(100): 1.05     MA(250): 1.16
MACD: MACD(12,26): -0.02     Signal(9): -0.02
Stochastic oscillator: %K(14,3): 59.71     %D(3): 59.19
RSI: RSI(14): 42.30
52-week: High: 3.15  Low: 0.78  Change(%): -29.8
Average Vol(K): 3-Month: 23821  10-Days: 19282

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and BEARISH in mid-long term.
MBRX has closed above bottom band by 46.3%. Bollinger Bands are 42.7% narrower than normal. The narrow width of the bands suggests low volatility as compared to MBRX's normal range. The bands have been in this narrow range for 0 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

Moleculin Announces New Data Shows Reversal of Tumor Activity in Animal Models
HOUSTON, Dec. 19, 2019 /PRNewswire/ -- Moleculin Biotech, Inc., (Nasdaq: MBRX) ("Moleculin" or the "Company"), a clinical stage pharmaceutical company with a broad portfolio of drug candidates targeting highly resistant tumors, today announced the presentation of a poster entitled,…

Moleculin Announces Additional Positive Interim Results from Phase 1/2 Clinical Studies of Annamycin in Acute Myeloid Leukemia
/PRNewswire/ -- Moleculin Biotech, Inc., (Nasdaq: MBRX) ("Moleculin" or the "Company"), a clinical stage pharmaceutical company with a broad portfolio of drug…

Financial Analysis

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Tweet this page Share on Facebook
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ Capital Market
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 45.73
Shares Float (M) 37.89
% Held by Insiders 15.12
% Held by Institutions 15.05
Shares Short (K) 1870
Shares Short P. Month (K)

Stock Financials

EPS -0.337
Book Value (p.s.) 0.410
PEG Ratio
Profit Margin
Operating Margin
Return on Assets (ttm) -41.5
Return on Equity (ttm) -71.8
Qtrly Rev. Growth
Gross Profit (p.s.)
Sales Per Share
EBITDA (p.s.) -0.369
Qtrly Earnings Growth
Operating Cash Flow (M) -15.63
Levered Free Cash Flow (M) -3.57

Stock Valuations

P/E -2.77
P/E Growth Ratio -0.03
P/BV 2.28
P/CF -2.73

Dividends & Splits

Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Forward Dividend
Last Split Date
Last Split Ratio -1e+010
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2019 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.